Группа авторов

Shockwave Medicine


Скачать книгу

      92Vincent KC: Medical Shockwaves a Treatment Option for Complex and Neuropathic Pain Syndromes? A Compilation of Case Reports. 17th Scientific Congress of the International Society for Medical Shockwave Treatment, 26th–28th, Milan, Italy, 2014.

      96Mariotto S, de Prati AC, Cavalieri E, Amelio E, Marlinghaus E, Suzuki H: Extracorporeal shock wave therapy in inflammatory diseases: molecular mechanism that triggers anti-inflammatory action. Curr Med Chem 2009;16:2366–2372.

      98Stojadinovic A, Elster EA, Anam K, Tadaki D, Amare M, Zins S, Davis TA: Angiogenic response to extracorporeal shock wave treatment in murine skin isografts. Angiogenesis 2008;11:369–380.

      101Hausdorf J, Sievers B, Schmitt-Sody M, Jansson V, Maier M, Mayer-Wagner S: Stimulation of bone growth factor synthesis in human osteoblasts and fibroblasts after extracorporeal shock wave application. Arch Orthop Trauma Surg 2011;131:303–309.

      102Kearney CJ, Hsu HP, Spector M: The use of extracorporeal shock wave-stimulated periosteal cells for orthotopic bone generation. Tissue Eng Part A 2012;18:1500–1508.

      105Christov C, Chretien F, Abou-Khalil R, Bassez G, Vallet G, Authier FJ, et al: Muscle satellite cells and endothelial cells: close neighbors and privileged partners. Mol Biol Cell 2007;18:1397–1409.

      106Mounier R, Chretien F, Chazaud B: Blood vessels and the satellite cell niche. Curr Top Dev Biol 2011;96:121–138.

      107Ceafalan LC, Popescu BO, Hinescu ME: Cellular players in skeletal muscle regeneration. Bio Med Res Int 2014;2014:957014.

      108Elsafadi M, Manikandan M, Dawud RA, Alajez NM, Hamam R, Alfayez M, et al: Transgelin is a TGFβ-inducible gene that regulates osteoblastic and adipogenic differentiation of human skeletal stem cells through actin cytoskeleston organization. Cell Death Dis 2016;7:e2321.

      109Bentzinger CF, Wang YX, Dumont NA, Rudnicki MA: Cellular dynamics in the muscle satellite cell niche. EMBO Rep 2013;14:1062–1072.

      110Pevsner-Fischer M, Morad V, Cohen-Sfady M, Russso-Noori L, Zanin-Zhorov A, Cohen IR, et al: Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007;109:1422–1432.

      111Qi C, Xiaofeng X, Xiaoguang W: Effects of Toll-Like Receptors 3 and 4 in the Osteogenesis of Stem Cells. Stem Cell Int 2014;2014:917168.

      112Delarosa O, Dalemans W, Lombardo E: Toll-like receptors as modulators of mesenchymal stem cells. Front Immunol 2012;3:182.

      113Shirjang S, Mansoori B, Solali S, Hagh MF, Shamsasenjan K: Toll-like receptors as a key regulator of mesenchymal stem cell function: an up-to-date review. Cell Immunol 2017;315:1–10.

      116Orr AW, Helmke BP, Blackman BR, Schwartz MA: Mechanisms of Mechanotransduction. Dev Cell 2006;10:11–20.

      117Huang H, Kamm RD, Lee RT: Cell mechanics and mechanotransduction: pathways, probes, and physiology. Am J Physiol 2004;287:C1–C11.

      118Chen CS: Mechanotransduction – a field pulling together? J Cell Sci 2008;121:3285–3292.

      119Chiquet